Correlation Between Salesforce and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Salesforce and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Karyopharm Therapeutics, you can compare the effects of market volatilities on Salesforce and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Karyopharm Therapeutics.
Diversification Opportunities for Salesforce and Karyopharm Therapeutics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Salesforce and Karyopharm is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Salesforce and Karyopharm Therapeutics
Considering the 90-day investment horizon Salesforce is expected to generate 0.59 times more return on investment than Karyopharm Therapeutics. However, Salesforce is 1.68 times less risky than Karyopharm Therapeutics. It trades about -0.31 of its potential returns per unit of risk. Karyopharm Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 34,710 in Salesforce on November 27, 2024 and sell it today you would lose (3,878) from holding Salesforce or give up 11.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Salesforce |
| Karyopharm Therapeutics |
Salesforce and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Karyopharm Therapeutics
The main advantage of trading using opposite Salesforce and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |